Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Pfizer describes a new series of CRF antagonists

Nov. 1, 1996

Japanese researchers disclose glutamate antagonists

Nov. 1, 1996

Alzheimer's disease linked to immunoinflammatory response

Nov. 1, 1996

Eisai files for approval of Aricept

Nov. 1, 1996

Meiji Seika discloses compounds that enhance axonal regeneration

Nov. 1, 1996

Merck NK1 antagonist shows antiemetic activity in ferrets

Nov. 1, 1996

N-type calcium channel blockers from Sankyo

Nov. 1, 1996

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

Anxiolytic activity of phytomedicine established in patients

Nov. 1, 1996

Melatonergic agents reported by BMS

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...